BioMarin Pharmaceutical Inc. buy Morgan Stanley
Start price
26.04.24
/
50%
€75.64
Target price
26.04.25
€104.69
Performance (%)
-26.63%
End price
27.04.25
€55.50
Summary
This prediction ended on 27.04.25 with a price of €55.50. The price of BioMarin Pharmaceutical Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -26.63%. Morgan_Stanley has a follow-up prediction for BioMarin Pharmaceutical Inc. where he still thinks BioMarin Pharmaceutical Inc. is a Buy. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| BioMarin Pharmaceutical Inc. | -0.838% | -0.838% | -23.131% |
| iShares Core DAX® | 0,05 % | 1,31 % | 11,38 % |
| iShares Nasdaq 100 | 1,60 % | -0,90 % | 7,29 % |
| iShares Nikkei 225® | 3,06 % | 12,95 % | 33,77 % |
| iShares S&P 500 | 0,82 % | 0,70 % | 4,93 % |
Comments by Morgan_Stanley for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its price target lowered by analysts at Morgan Stanley from $115.00 to $112.00. They now have an "overweight" rating on the stock.
Ratings data for BMRN provided by MarketBeat
In the thread Trading BioMarin Pharmaceutical Inc.
Die von Morgan_Stanley gewählte maximale Laufzeit wurde überschritten
Current prediction by Morgan_Stanley for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€48.80
03.07.25
03.07.25
€82.17
03.07.26
03.07.26
6.02%
16:36
16:36
Stopped prediction by Morgan_Stanley for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€46.90
28.10.25
28.10.25
€84.06
28.10.26
28.10.26
10.32%
16:36
16:36
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€50.36
22.07.25
22.07.25
€82.12
22.07.26
22.07.26
2.74%
16:36
16:36
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€79.72
01.08.23
01.08.23
€113.91
01.08.24
01.08.24
-3.59%
02.08.24
02.08.24